Company intelligence / Profile preview

IonOpticks

Fitzroy, Victoria, Australiaionopticks.com ↗

Ownership: Private
Development stage: Commercial

Overview

IonOpticks develops and manufactures advanced chromatography columns—most notably the Aurora Series—for use in liquid chromatography-mass spectrometry (LC-MS), primarily supporting high-end proteomics research. Their products are recognized for enhancing sensitivity, throughput, robustness, and reproducibility of mass spectrometry analyses. These tools are widely adopted by researchers globally to advance drug discovery, clinical proteomics, bioprocessing development, phosphoproteomics, and shotgun proteomics. The company collaborates closely with leading academic institutions and industry partners to drive innovation in analytical workflows.

Industry: Chemicals & Materials

Partnerships

Adelis Equity Partners

Beyond the preview

Go deeper on IonOpticks.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IonOpticks.

Explore the full profile